U.S. flag

An official website of the United States government

NM_000535.7(PMS2):c.247_250dup (p.Thr84fs) AND Lynch syndrome

Germline classification:
Pathogenic (1 submission)
Last evaluated:
Jan 4, 2024
Review status:
1 star out of maximum of 4 stars
criteria provided, single submitter
Somatic classification
of clinical impact:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Somatic classification
of oncogenicity:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Record status:
current
Accession:
RCV004003328.2

Allele description [Variation Report for NM_000535.7(PMS2):c.247_250dup (p.Thr84fs)]

NM_000535.7(PMS2):c.247_250dup (p.Thr84fs)

Gene:
PMS2:PMS1 homolog 2, mismatch repair system component [Gene - OMIM - HGNC]
Variant type:
Duplication
Cytogenetic location:
7p22.1
Genomic location:
Preferred name:
NM_000535.7(PMS2):c.247_250dup (p.Thr84fs)
HGVS:
  • NC_000007.14:g.6003972_6003975dup
  • NG_008466.1:g.10132_10135dup
  • NM_000535.7:c.247_250dupMANE SELECT
  • NM_001322003.2:c.-159_-156dup
  • NM_001322004.2:c.-159_-156dup
  • NM_001322005.2:c.-159_-156dup
  • NM_001322006.2:c.247_250dup
  • NM_001322007.2:c.32_35dup
  • NM_001322008.2:c.32_35dup
  • NM_001322009.2:c.-159_-156dup
  • NM_001322010.2:c.-159_-156dup
  • NM_001322011.2:c.-638_-635dup
  • NM_001322012.2:c.-638_-635dup
  • NM_001322013.2:c.-159_-156dup
  • NM_001322014.2:c.247_250dup
  • NM_001322015.2:c.-238_-235dup
  • NP_000526.2:p.Thr84fs
  • NP_001308935.1:p.Thr84fs
  • NP_001308936.1:p.Asn12_Asp13insTer
  • NP_001308937.1:p.Asn12_Asp13insTer
  • NP_001308943.1:p.Thr84fs
  • LRG_161t1:c.247_250dup
  • LRG_161:g.10132_10135dup
  • NC_000007.13:g.6043602_6043603insTTAA
  • NC_000007.13:g.6043603_6043606dup
  • NM_000535.5:c.247_250dupTTAA
  • NR_136154.1:n.334_337dup
Protein change:
T84fs
Links:
dbSNP: rs1554304940
NCBI 1000 Genomes Browser:
rs1554304940
Molecular consequence:
  • NM_001322003.2:c.-159_-156dup - 5 prime UTR variant - [Sequence Ontology: SO:0001623]
  • NM_001322004.2:c.-159_-156dup - 5 prime UTR variant - [Sequence Ontology: SO:0001623]
  • NM_001322005.2:c.-159_-156dup - 5 prime UTR variant - [Sequence Ontology: SO:0001623]
  • NM_001322009.2:c.-159_-156dup - 5 prime UTR variant - [Sequence Ontology: SO:0001623]
  • NM_001322010.2:c.-159_-156dup - 5 prime UTR variant - [Sequence Ontology: SO:0001623]
  • NM_001322011.2:c.-638_-635dup - 5 prime UTR variant - [Sequence Ontology: SO:0001623]
  • NM_001322012.2:c.-638_-635dup - 5 prime UTR variant - [Sequence Ontology: SO:0001623]
  • NM_001322013.2:c.-159_-156dup - 5 prime UTR variant - [Sequence Ontology: SO:0001623]
  • NM_001322015.2:c.-238_-235dup - 5 prime UTR variant - [Sequence Ontology: SO:0001623]
  • NM_000535.7:c.247_250dup - frameshift variant - [Sequence Ontology: SO:0001589]
  • NM_001322006.2:c.247_250dup - frameshift variant - [Sequence Ontology: SO:0001589]
  • NM_001322014.2:c.247_250dup - frameshift variant - [Sequence Ontology: SO:0001589]
  • NM_001322007.2:c.32_35dup - inframe_insertion - [Sequence Ontology: SO:0001821]
  • NM_001322008.2:c.32_35dup - inframe_insertion - [Sequence Ontology: SO:0001821]
  • NR_136154.1:n.334_337dup - non-coding transcript variant - [Sequence Ontology: SO:0001619]
  • NM_001322007.2:c.32_35dup - nonsense - [Sequence Ontology: SO:0001587]
  • NM_001322008.2:c.32_35dup - nonsense - [Sequence Ontology: SO:0001587]
Observations:
1

Condition(s)

Name:
Lynch syndrome
Identifiers:
MONDO: MONDO:0005835; MedGen: C4552100

Recent activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...

Assertion and evidence details

Submission AccessionSubmitterReview Status
(Assertion method)
Clinical Significance
(Last evaluated)
OriginMethodCitations
SCV004814296All of Us Research Program, National Institutes of Health
criteria provided, single submitter

(ACMG Guidelines, 2015)
Pathogenic
(Jan 4, 2024)
germlineclinical testing

PubMed (6)
[See all records that cite these PMIDs]

Summary from all submissions

EthnicityOriginAffectedIndividualsFamiliesChromosomes testedNumber TestedFamily historyMethod
not providedgermlineunknown1not providednot provided108544not providedclinical testing

Citations

PubMed

Germline MLH1 Mutations Are Frequently Identified in Lynch Syndrome Patients With Colorectal and Endometrial Carcinoma Demonstrating Isolated Loss of PMS2 Immunohistochemical Expression.

Dudley B, Brand RE, Thull D, Bahary N, Nikiforova MN, Pai RK.

Am J Surg Pathol. 2015 Aug;39(8):1114-20. doi: 10.1097/PAS.0000000000000425.

PubMed [citation]
PMID:
25871621

Cancer prevention by aspirin in children with Constitutional Mismatch Repair Deficiency (CMMRD).

Leenders EKSM, Westdorp H, Brüggemann RJ, Loeffen J, Kratz C, Burn J, Hoogerbrugge N, Jongmans MCJ.

Eur J Hum Genet. 2018 Oct;26(10):1417-1423. doi: 10.1038/s41431-018-0197-0. Epub 2018 Jun 14. Review.

PubMed [citation]
PMID:
29904176
PMCID:
PMC6138701
See all PubMed Citations (6)

Details of each submission

From All of Us Research Program, National Institutes of Health, SCV004814296.1

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not provided1not providednot providedclinical testing PubMed (6)

Description

This variant is predicted to result in loss of protein function through nonsense-mediated decay or protein truncation. Loss of function is an established mechanism of disease. This variant has been reported in multiple individuals with PMS2-related cancer (PMID: 25871621, 33693762, 34873870). It has also been reported in the compound heterozygous state with another PMS2 variant in a child with constitutional mismatch repair deficiency (PMID: 29904176, 34964038). This variant is absent from large population databases, including the Genome Aggregation Database (http://gnomad.broadinstitute.org/).

#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlineunknown108544not providednot provided1not providednot providednot provided

Last Updated: Sep 29, 2024